Sort
34,240 grants matching “atherosclerosis”
Modulation of Hepcidin-Ferroportin Signaling using Small Molecules
$502,260Randall T Peterson · Massachusetts General Hospital · R01 · FY2015 · DK
Modulation of Hepcidin-Ferroportin Signaling using Small Molecules
$502,260Donald B Bloch · Massachusetts General Hospital · R01 · FY2017 · DK
GENCAC - Utah Field Center
$502,199University Of Utah · U01 · FY2002 · HL
PCSK9, Lipoprotein receptors, and Atherosclerosis
$502,190Sergio Fazio · Vanderbilt University · R01 · FY2012 · HL
Scavenger Receptors: Ligand Binding and Pathophysiology
$502,144Monty Krieger · Massachusetts Institute Of Technology · R01 · FY2010 · HL
Pathways to cardiovascular disease prevention and impact of specialty referral in under-represented racial/ethnic minorities with HIV
$502,121Gerald Samuel Bloomfield · Duke University · R01 · FY2022 · MD
Genetics of Cardiovascular Disease in Chronic Kidney Disease
$502,111Nora Franceschini · Univ Of North Carolina Chapel Hill · R01 · FY2022 · HL
Early Imaging Detection of CV Injury after Cancer
$502,024William Gregory Hundley · Wake Forest University Health Sciences · R01 · FY2016 · CA
THE ATHEROSCLEROSIS RISK IN COMMUNITIES (ARIC) STUDY - FIELD CENTER - TASK AREA B
$501,993Elizabeth Selvin · Johns Hopkins University · N01 · FY2024 · HL
MR evaluation of macro- and micro-vascularity in diabetic peripheral artery disease
$501,922Mitsue Miyazaki · University Of California, San Diego · R01 · FY2023 · HL
MR evaluation of macro- and micro-vascularity in diabetic peripheral artery disease
$501,922Mitsue Miyazaki · University Of California, San Diego · R01 · FY2022 · HL
BLOOD FACTORS AND PERIPHERAL ARTERIAL DISEASE OUTCOMES
$501,878Northwestern University · R01 · FY2004 · HL
RAGE, DIAPH1 and IRF7 and Macrophage Dysfunction in Atherosclerosis and Cardiometabolic Disease
$501,779Ann Marie Schmidt · New York University School Of Medicine · P01 · FY2022 · HL
RAGE, DIAPH1 and IRF7 and Macrophage Dysfunction in Atherosclerosis and Cardiometabolic Disease
$501,779Ann Marie Schmidt · New York University School Of Medicine · P01 · FY2023 · HL
Mild Cognitive Impairment: Cerebrovascular Dysfunction and Exercise Training
$501,729Rong Zhang · Ut Southwestern Medical Center · R01 · FY2009 · AG
MORBIDITY AND MORTALITY RELATED TO GASTRIC BYPASS SURGERY
$501,714Steven C. Hunt · University Of Utah · R01 · FY2009 · DK
Ath 11 is complex: Raet1e and Esr1 as candidate genes; their mechanisms of action
$501,695Jan L Breslow · Rockefeller University · R01 · FY2013 · HL
Enhancing Recovery After Cardiac Surgery
$501,686Lynn Valerie Doering · University Of California Los Angeles · R01 · FY2007 · NR
Novel Collagen-Based Peripheral Endoprosthesis
$501,659Collagen Matrix, Inc. · R44 · FY2002 · HL
Project 2: Smooth muscle cell programs for coronary artery disease
$501,611Thomas None Quertermous · Stanford University · P01 · FY2025 · HL
CAREER: Biochemical and Biomechanical Interaction within the Endothelial Cell - Basement Membrane Co-Regulatory Unit
$501,591Alisa M Clyne · Drexel University · · FY2009 · ENG
ADIPOSE REMODELING & VASCULAR PHENOTYPES IN OBESITY
$501,579Noyan Gokce · Boston University Medical Campus · P01 · FY2013 · HL
Mechanisms regulating the atherogenic activities of serum amyloid A
$501,577Lisa R Tannock · University Of Kentucky · R01 · FY2021 · HL
Mechanisms regulating the atherogenic activities of serum amyloid A
$501,577Lisa R Tannock · University Of Kentucky · R01 · FY2022 · HL
Mechanisms regulating the atherogenic activities of serum amyloid A
$501,577Lisa R Tannock · University Of Kentucky · R01 · FY2020 · HL